Introduction

Date 28 September 2014
Event ESMO 2014
Session Residual disease after neoadjuvant therapies
Topics Anticancer agents
Breast Cancer
Therapy
Biological Therapy
Presenter Suzette Delaloge
Authors S. Delaloge
  • Breast Cancer Unit, Department Of Medical Oncology, Institut Gustave Roussy, 94805 - Villejuif/FR